Biogen price target lowered to $241 from $300 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Biogen (BIIB) to $241 from $300 and keeps a Buy rating on the shares. The firm says that ...
Biogen (BIIB) Gets a Buy from Mizuho Securities
Mizuho Securities analyst Salim Syed maintained a Buy rating on Biogen (BIIB – Research Report) yesterday and set a price target of $207.00.